METHOD FOR TREATING NEOPLASMS AND ANTITUMOR COMBINATION CONTAINING 42-MEMBERED ESTER OF RAPAMICINE WITH 3-HYDROXY-2-(HYDROXYMETHYL)-2-METHYLPROPIONIC ACID (CCI-779) AND GEMSITABINE OR FLUOROURACIL

摘要

The invention provides the use of a combination of an mTOR inhibitor such as a rapimycin and an antimetabolite antineoplastic agent such as gemsitabine or fluorouracil in the treatment of neoplasms.